Personalis Inc. PSNL
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Personalis Inc. is a biotechnology company specializing in advanced genomics services for precision medicine and oncology. Its primary function is to analyze complex genetic information for clinical and academic research, aiding in the development of targeted therapeutics and personalized treatments. The company's offe…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees259
TickerPSNL
Statistics
Market Cap$1.02B
Revenue (TTM)$69.6M
Net Income-$81.3M
Net Margin-116.7%
EPS$-0.91
P/E-10.36
P/S15.29
P/B3.87
EV/EBITDA-8.76
ROE-41.4%
Dividend Yield—
Price$9.78
Data: Twelve Data · Revenue = mcap / P/S